Research progresses in the pathogenesis of anaplastic large cell lymphoma

Anaplastic large cell lymphoma （ALCL） is a distinct subset of 3--cell non-Hodgkin＇s lymphoma. As a consequence of its low incidence, general pathogenic consideration of ALCL is lacking. In this review, we summarize the pathogenesis, epidemiology, clinical manifestations, and treatment of ALCL, so as...

Full description

Saved in:
Bibliographic Details
Published in:Ai zheng 2011-06, Vol.30 (6), p.392-399
Main Authors: Shi, Xiao-Lan, Tang, Xiao-Wen, Wu, De-Pei
Format: Article
Language:English
Subjects:
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Combined Modality Therapy
Humans
Ki-1 Antigen - metabolism
Lymphoma, Large-Cell, Anaplastic - epidemiology
Lymphoma, Large-Cell, Anaplastic - etiology
Lymphoma, Large-Cell, Anaplastic - metabolism
Lymphoma, Large-Cell, Anaplastic - therapy
Radiotherapy
Receptor Protein-Tyrosine Kinases - metabolism
Review
Stem Cell Transplantation
临床表现
发病机制
发病机理
发病率
变性
流行病学
淋巴瘤
细胞
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anaplastic large cell lymphoma （ALCL） is a distinct subset of 3--cell non-Hodgkin＇s lymphoma. As a consequence of its low incidence, general pathogenic consideration of ALCL is lacking. In this review, we summarize the pathogenesis, epidemiology, clinical manifestations, and treatment of ALCL, so as to better understand key stages of the development of this disease and provide valuable information for future treatment.
ISSN:1000-467X
1944-446X
DOI:10.5732/cjc.010.10361